(Q45960190)

18 December 2017

title

Ezetimibe inhibits the incorporation of dietary oxidized cholesterol into lipoproteins. (English)

1 reference

18 December 2017

1 reference

Ilona Staprans

1

1 reference

18 December 2017

Xian-Mang Pan

2

1 reference

18 December 2017

Joseph H Rapp

3

1 reference

18 December 2017

Arthur H Moser

4

1 reference

18 December 2017

Kenneth R Feingold

5

1 reference

18 December 2017

publication date

7 August 2006

1 reference

18 December 2017

Journal of Lipid Research

published in

1 reference

18 December 2017

volume

47

1 reference

18 December 2017

page(s)

2575-2580

1 reference

18 December 2017

issue

11

1 reference

18 December 2017

Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Low density lipoprotein undergoes oxidative modification in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Occurrence of lipid oxidation products in foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Oxidized cholesterol in the diet accelerates the development of atherosclerosis in LDL receptor- and apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Oxidized cholesterol in the diet accelerates the development of aortic atherosclerosis in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

The intestinal absorption of biliary and dietary cholesterol as a drug target for lowering the plasma cholesterol level

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Parameters influencing cholesterol oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Transport of cholesterol autoxidation products in rabbit lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Increased plasma 7 beta-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

Ezetimibe: the first in a novel class of selective cholesterol-absorption inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600261-JLR200

10.1194/JLR.M600261-JLR200

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

16894239

1 reference

18 December 2017